Prosoma

Prosoma is a medical company that creates digital therapeutic products for cancer patients. We have developed a portfolio of medical software products for digital therapeutics, covering the entire range of behavioral therapy needs for cancer patients. Our clinically validated platform will be prescribed by doctors and therapists in Germany and will be reimbursed by the local healthcare system in the first quarter of 2022. Our goal is to become the world's leading digital therapeutic solution in oncology, and we have a clear pathway to achieve this. Prosoma’s “Software as a Medical Device” platform consists of standalone applications tailored to different stages of the patient journey, including: symptom and treatment support, psycho-social support, and behavioral support. All these pathways are clinically validated and can be accessed anytime and anywhere the patient needs them. Our medical self-care app is designed to deliver personalized treatment based on each patient's diagnosis and outcomes. It is the most comprehensive tool to improve the lives of patients. Prosoma is developed by medical experts and patients. We collaborate with the most renowned clinical trial institutions and major commercial partners in the United States and Germany.